HDB-82

N/A

Report date: 2025/09/28 09:47:55
NME

Base Information

Drug NameHDB-82
Drug Alias NameHDB-82
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionKRAS G12D degraders
TargetsKRAS G12D
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBNJ BiopharmaHandok Inc
China Registration ClassN/A

Develop Information

Active CompaniesBNJ BiopharmaHandok Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A